Active — Not RecruitingNot Applicable

Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study

United States256 participantsStarted 2021-07-23

Plain-language summary

This clinical trial studies the effect of a culturally based brief expressive writing intervention in improving the health of Chinese immigrant stage 0-III breast cancer survivors. Culturally based brief expressive writing interventions may help researchers learn more about the experiences of Chinese immigrant breast cancer survivors and how writing about their experiences may affect their health.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Being diagnosed with stage 0-III breast cancer.
✓. Completed primary treatment, including surgery, chemotherapy, radiation therapy, immune therapy, and/or targeted therapy within the preceding 5 years.
✓. Foreign-born Chinese women (aged 18 and older) who lived in the U.S. for at least six months in the past.

What they're measuring

Quality of life (QOL)

Timeframe: Up to 12 months

Trial details

NCT IDNCT04754412

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-01

View on ClinicalTrials.gov More Anatomic Stage 0 Breast Cancer AJCC v8 trials